당뇨병 검사 프로그램 시장 : 인사이트 및 예측(-2030년)

The global Diabetes Testing Program market is projected to grow from US$ 2,504.20 million in 2024 to US$ 3,872.15 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.53% during the forecast period.

The United States & Canada market for Diabetes Testing Program is estimated to increase from $ 503.02 million in 2024 to reach $ 769.48 million by 2030, at a CAGR of 7.34% during the forecast period of 2025 through 2030.

The China market for Diabetes Testing Program is estimated to increase from $ 842.84 million in 2024 to reach $ 1,337.16 million by 2030, at a CAGR of 8.00% during the forecast period of 2025 through 2030.

The Europe market for Diabetes Testing Program is estimated to increase from $ 312.03 million in 2024 to reach $ 447.37 million by 2030, at a CAGR of 6.19% during the forecast period of 2025 through 2030.

The global key manufacturers of Diabetes Testing Program include Abbott Laboratories, Roche, Siemens, LifeScan, Bio-Rad Laboratories, etc. In 2023, the global top five players had a share approximately 64.41% in terms of revenue.

Report Includes

This report presents an overview of global market for Diabetes Testing Program, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Diabetes Testing Program, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diabetes Testing Program, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetes Testing Program sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diabetes Testing Program market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diabetes Testing Program sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, LifeScan, Abbott Laboratories, Ascensia, Arkray, I-SENS, Omron, Braun, and Siemens, etc.

Market Segmentation

By Company

• Abbott Laboratories
• Roche
• Siemens
• LifeScan
• Bio-Rad Laboratories
• Sinocare
• Tosoh
• Ascensia
• Danaher Corporation
• Trinity Biotech
• Acon Biotech
• Terumo
• Arkray
• HUMAN Diagnostics
• Braun
• I-SENS
• Omron

Segment by Type

• HbA1c Test
• Finger-prick Test

Segment by Application

• Medical Diagnosis
• Home Test
• Lab Testing

Segment by Region

US & Canada

• U.S.
• Canada

China

Asia (excluding China)

• Japan
• South Korea
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• U.K.
• Italy
• Russia

Middle East, Africa, Latin America

• Brazil
• Mexico
• Turkey
• Israel
• GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Diabetes Testing Program in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Diabetes Testing Program manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Testing Program sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

• 1.1 Diabetes Testing Program Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Diabetes Testing Program Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 HbA1c Test
  • 1.2.3 Finger-prick Test
• 1.3 Market by Application
  • 1.3.1 Global Diabetes Testing Program Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Medical Diagnosis
  • 1.3.3 Home Test
  • 1.3.4 Lab Testing
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 EXECUTIVE SUMMARY

• 2.1 Global Diabetes Testing Program Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Diabetes Testing Program Revenue by Region
  • 2.2.1 Global Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Diabetes Testing Program Revenue by Region (2019-2024)
  • 2.2.3 Global Diabetes Testing Program Revenue by Region (2025-2030)
  • 2.2.4 Global Diabetes Testing Program Revenue Market Share by Region (2019-2030)
• 2.3 Global Diabetes Testing Program Sales Estimates and Forecasts 2019-2030
• 2.4 Global Diabetes Testing Program Sales by Region
  • 2.4.1 Global Diabetes Testing Program Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Diabetes Testing Program Sales by Region (2019-2024)
  • 2.4.3 Global Diabetes Testing Program Sales by Region (2025-2030)
  • 2.4.4 Global Diabetes Testing Program Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURERS

• 3.1 Global Diabetes Testing Program Sales by Manufacturers
  • 3.1.1 Global Diabetes Testing Program Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Diabetes Testing Program Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diabetes Testing Program in 2023
• 3.2 Global Diabetes Testing Program Revenue by Manufacturers
  • 3.2.1 Global Diabetes Testing Program Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Diabetes Testing Program Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Diabetes Testing Program Revenue in 2023
• 3.3 Global Key Players of Diabetes Testing Program, Industry Ranking, 2021 VS 2022
• 3.4 Global Diabetes Testing Program Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Diabetes Testing Program Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Diabetes Testing Program, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Diabetes Testing Program, Product Offered
• 3.8 Global Key Manufacturers of Diabetes Testing Program, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

• 4.1 Global Diabetes Testing Program Sales by Type
  • 4.1.1 Global Diabetes Testing Program Historical Sales by Type (2019-2024)
  • 4.1.2 Global Diabetes Testing Program Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Diabetes Testing Program Sales Market Share by Type (2019-2030)
• 4.2 Global Diabetes Testing Program Revenue by Type
  • 4.2.1 Global Diabetes Testing Program Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Diabetes Testing Program Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Diabetes Testing Program Revenue Market Share by Type (2019-2030)
• 4.3 Global Diabetes Testing Program Price by Type
  • 4.3.1 Global Diabetes Testing Program Price by Type (2019-2024)
  • 4.3.2 Global Diabetes Testing Program Price Forecast by Type (2025-2030)

5 MARKET SIZE BY APPLICATION

• 5.1 Global Diabetes Testing Program Sales by Application
  • 5.1.1 Global Diabetes Testing Program Historical Sales by Application (2019-2024)
  • 5.1.2 Global Diabetes Testing Program Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Diabetes Testing Program Sales Market Share by Application (2019-2030)
• 5.2 Global Diabetes Testing Program Revenue by Application
  • 5.2.1 Global Diabetes Testing Program Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Diabetes Testing Program Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Diabetes Testing Program Revenue Market Share by Application (2019-2030)
• 5.3 Global Diabetes Testing Program Price by Application
  • 5.3.1 Global Diabetes Testing Program Price by Application (2019-2024)
  • 5.3.2 Global Diabetes Testing Program Price Forecast by Application (2025-2030)

6 US & CANADA

• 6.1 US & Canada Diabetes Testing Program Market Size by Type
  • 6.1.1 US & Canada Diabetes Testing Program Sales by Type (2019-2030)
  • 6.1.2 US & Canada Diabetes Testing Program Revenue by Type (2019-2030)
• 6.2 US & Canada Diabetes Testing Program Market Size by Application
  • 6.2.1 US & Canada Diabetes Testing Program Sales by Application (2019-2030)
  • 6.2.2 US & Canada Diabetes Testing Program Revenue by Application (2019-2030)
• 6.3 US & Canada Diabetes Testing Program Market Size by Country
  • 6.3.1 US & Canada Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Diabetes Testing Program Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Diabetes Testing Program Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 EUROPE

• 7.1 Europe Diabetes Testing Program Market Size by Type
  • 7.1.1 Europe Diabetes Testing Program Sales by Type (2019-2030)
  • 7.1.2 Europe Diabetes Testing Program Revenue by Type (2019-2030)
• 7.2 Europe Diabetes Testing Program Market Size by Application
  • 7.2.1 Europe Diabetes Testing Program Sales by Application (2019-2030)
  • 7.2.2 Europe Diabetes Testing Program Revenue by Application (2019-2030)
• 7.3 Europe Diabetes Testing Program Market Size by Country
  • 7.3.1 Europe Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Diabetes Testing Program Revenue by Country (2019-2030)
  • 7.3.3 Europe Diabetes Testing Program Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 CHINA

• 8.1 China Diabetes Testing Program Market Size by Type
  • 8.1.1 China Diabetes Testing Program Sales by Type (2019-2030)
  • 8.1.2 China Diabetes Testing Program Revenue by Type (2019-2030)
• 8.2 China Diabetes Testing Program Market Size by Application
  • 8.2.1 China Diabetes Testing Program Sales by Application (2019-2030)
  • 8.2.2 China Diabetes Testing Program Revenue by Application (2019-2030)

9 ASIA (EXCLUDING CHINA)

• 9.1 Asia Diabetes Testing Program Market Size by Type
  • 9.1.1 Asia Diabetes Testing Program Sales by Type (2019-2030)
  • 9.1.2 Asia Diabetes Testing Program Revenue by Type (2019-2030)
• 9.2 Asia Diabetes Testing Program Market Size by Application
  • 9.2.1 Asia Diabetes Testing Program Sales by Application (2019-2030)
  • 9.2.2 Asia Diabetes Testing Program Revenue by Application (2019-2030)
• 9.3 Asia Diabetes Testing Program Market Size by Region
  • 9.3.1 Asia Diabetes Testing Program Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Diabetes Testing Program Revenue by Region (2019-2030)
  • 9.3.3 Asia Diabetes Testing Program Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 Southeast Asia
  • 9.3.7 India
  • 9.3.8 Australia

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

• 10.1 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Diabetes Testing Program Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Diabetes Testing Program Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Diabetes Testing Program Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Diabetes Testing Program Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 CORPORATE PROFILE

• 11.1 Abbott Laboratories
  • 11.1.1 Abbott Laboratories Company Information
  • 11.1.2 Abbott Laboratories Overview
  • 11.1.3 Abbott Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Abbott Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Abbott Laboratories Recent Developments
• 11.2 Roche
  • 11.2.1 Roche Company Information
  • 11.2.2 Roche Overview
  • 11.2.3 Roche Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Roche Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Roche Recent Developments
• 11.3 Siemens
  • 11.3.1 Siemens Company Information
  • 11.3.2 Siemens Overview
  • 11.3.3 Siemens Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Siemens Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Siemens Recent Developments
• 11.4 LifeScan
  • 11.4.1 LifeScan Company Information
  • 11.4.2 LifeScan Overview
  • 11.4.3 LifeScan Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.5 Bio-Rad Laboratories
  • 11.5.1 Bio-Rad Laboratories Company Information
  • 11.5.2 Bio-Rad Laboratories Overview
  • 11.5.3 Bio-Rad Laboratories Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Bio-Rad Laboratories Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Bio-Rad Laboratories Recent Developments
• 11.6 Sinocare
  • 11.6.1 Sinocare Company Information
  • 11.6.2 Sinocare Overview
  • 11.6.3 Sinocare Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Sinocare Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.7 Tosoh
  • 11.7.1 Tosoh Company Information
  • 11.7.2 Tosoh Overview
  • 11.7.3 Tosoh Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Tosoh Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Tosoh Recent Developments
• 11.8 Ascensia
  • 11.8.1 Ascensia Company Information
  • 11.8.2 Ascensia Overview
  • 11.8.3 Ascensia Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Ascensia Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.9 Danaher Corporation
  • 11.9.1 Danaher Corporation Company Information
  • 11.9.2 Danaher Corporation Overview
  • 11.9.3 Danaher Corporation Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Danaher Corporation Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Danaher Corporation Recent Developments
• 11.10 Trinity Biotech
  • 11.10.1 Trinity Biotech Company Information
  • 11.10.2 Trinity Biotech Overview
  • 11.10.3 Trinity Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Trinity Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Trinity Biotech Recent Developments
• 11.11 Acon Biotech
  • 11.11.1 Acon Biotech Company Information
  • 11.11.2 Acon Biotech Overview
  • 11.11.3 Acon Biotech Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Acon Biotech Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.12 Terumo
  • 11.12.1 Terumo Company Information
  • 11.12.2 Terumo Overview
  • 11.12.3 Terumo Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Terumo Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Terumo Recent Developments
• 11.13 Arkray
  • 11.13.1 Arkray Company Information
  • 11.13.2 Arkray Overview
  • 11.13.3 Arkray Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Arkray Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.14 HUMAN Diagnostics
  • 11.14.1 HUMAN Diagnostics Company Information
  • 11.14.2 HUMAN Diagnostics Overview
  • 11.14.3 HUMAN Diagnostics Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.14.4 HUMAN Diagnostics Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
• 11.15 Braun
  • 11.15.1 Braun Company Information
  • 11.15.2 Braun Overview
  • 11.15.3 Braun Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.15.4 Braun Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Braun Recent Developments
• 11.16 I-SENS
  • 11.16.1 I-SENS Company Information
  • 11.16.2 I-SENS Overview
  • 11.16.3 I-SENS Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.16.4 I-SENS Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 I-SENS Recent Developments
• 11.17 Omron
  • 11.17.1 Omron Company Information
  • 11.17.2 Omron Overview
  • 11.17.3 Omron Diabetes Testing Program Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.17.4 Omron Diabetes Testing Program Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Omron Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

• 12.1 Diabetes Testing Program Industry Chain Analysis
• 12.2 Diabetes Testing Program Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Diabetes Testing Program Production Mode & Process
• 12.4 Diabetes Testing Program Sales and Marketing
  • 12.4.1 Diabetes Testing Program Sales Channels
  • 12.4.2 Diabetes Testing Program Distributors
• 12.5 Diabetes Testing Program Customers

13 DIABETES TESTING PROGRAM MARKET DYNAMICS

• 13.1.1 Diabetes Testing Program Industry Trends
• 13.1.2 Diabetes Testing Program Market Drivers
• 13.1.3 Diabetes Testing Program Market Challenges
• 13.1.4 Diabetes Testing Program Market Restraints

14 KEY FINDINGS IN THE GLOBAL DIABETES TESTING PROGRAM STUDY

15 APPENDIX

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer